Company Overview

Development Stage

About the Company

Mianhua Reproductive Chain Group, with discipline construction as its core, has pioneered the integrated development model of "National Reproductive Chain Clinics + International Medical Pilot Zone Assisted Reproductive Hospital". Currently, it operates 30 reproductive clinics across 19 cities in 11 provinces, 1 tertiary hospital specializing in assisted reproduction (teaching base of Guangzhou University of Chinese Medicine), 8 hysteroscopy diagnosis and treatment centers, and 1 internet hospital. Mianhua breaks down the barriers of traditional hospital departments, establishing a reproductive specialized disease diagnosis and treatment system that integrates traditional Chinese and Western medicine, multidisciplinary collaboration, and refined diagnosis and treatment. It brings together numerous authoritative reproductive experts, systematically cultivates young and middle-aged backbone doctors with MDT thinking, focuses on difficult reproductive diseases, and achieves significant improvements in clinical diagnosis and treatment outcomes. As a nationally distributed reproductive specialty chain, Mianhua takes Beijing, Shanghai, and Guangzhou, the three major domestic core medical centers, as strategic fulcrums, and jointly with provincial capitals forms regional medical centers, extending high-quality reproductive medical resources to third- and fourth-tier cities, comprehensively enhancing the reproductive specialized disease diagnosis and treatment capabilities in various regions. In 2025, the number of reproductive disorder diagnoses and treatments was approximately 800,000, and in 2026 it is expected to increase to 1 million, ranking among the top in the country, with the number of outpatient visits for recurrent miscarriage and repeated IVF failure ranking first nationwide. It has built a zero-advertising, purely self-funded specialized disease diagnosis and treatment system, and is the reproductive specialty institution with the most layout cities in China.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (158 open positions)

Manage
Note: How fast is hiring at Guangzhou Mianhua Reproductive Medical Investment Co., Ltd. growing? 2026: 296 openings (down 14%), 2025: 346 openings (up 8%), 2024: 319 openings (up 80%), 2023: 177 openings (up 26%), 2022: 141 openings (up 14%), 2021: 124 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 35%
  • 2024: Up 37%
  • 2023: Up 59%
  • 2022: Up 164%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Guangzhou Mianhua Reproductive Medical Investment Co., Ltd. growing? Master's recruitment over the years: 2025: 85 openings (up 35%), 2024: 63 openings (up 37%), 2023: 46 openings (up 59%), 2022: 29 openings (up 164%), 2021: 11 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Guangzhou Mianhua Reproductive Medical Investment Co., Ltd.? Based on an analysis of 's job postings over the past year, "医疗卫生/美容保健类" demand: 76%, "计算机/网络/技术类": 12.6%, "科研类": 0.2%. For reference only.

— What Are the Salaries Like? (405 records)

Manage
salary range: 4.5K - 50K, 32.8% of roles pay ¥4.5-8K
Note: salary statistics are based on 405 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guangzhou Mianhua Reproductive Medical Investment Co., Ltd.?32.8% of positions earn 4.5-8K, Fresh graduate salary: ¥12.5K。医疗卫生/美容保健类 average salary ¥14.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Guangzhou Mianhua Reproductive Medical Investment Co., Ltd.? We provide: 妇科医生,运营,西医,新媒体,护士,医生助理,针灸,副总,药师,超声医生,前台,门诊经理,客服,采购,产科,市场,检验,b超,医务经理,护理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    77.5% of total 77.5%
  • 客户服务类
    23.6% of total 23.6%
  • 计算机/网络/技术类
    11.6% of total 11.6%
  • 经营管理类
    6.8% of total 6.8%

Education

  • 大专
    37% of total 37%
  • 本科
    31.4% of total 31.4%
  • 硕士
    28.4% of total 28.4%
  • 高中
    1.6% of total 1.6%

Experience

  • 1-3年
    29.1% of total 29.1%
  • 5-10年
    25.7% of total 25.7%
  • 3-5年
    25.2% of total 25.2%
  • 不限
    19.8% of total 19.8%
View Detailed Analysis

What does Guangzhou Mianhua Reproductive Medical Investment Co., Ltd. require? Who is Guangzhou Mianhua Reproductive Medical Investment Co., Ltd. hiring? recruitment: 医疗卫生/美容保健类占比最多占77.5%,其次是客户服务类占23.6%. What education can get in at ? 大专占比最多占37%,其次是本科占31.4%. High education required at ? 硕士占28.4%. Work experience required at ? 1-3年占比最多占29.1%,其次是5-10年占25.7%. Where are the job locations at ? 琼海占比最多占13.6%,其次是广州占12.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100万(元)
Legal Representative: 卢晓宏
Date Established:
Credit Code: 91440101MA5AK3H35A
Registered Address: 广州市白云区云城南二路173号116、117房

People who follow this company also follow

Competitors (Similar Companies)

“Automotive parts, molds and fixtures”
“Products for the diagnosis and treatment of allergic diseases”
“Innovating with smart transportation to address global challenges in m”
“Helping everyone eat better, live better”
V
“Committed to enhancing students' lifelong competitiveness, shaping the”
物联网/IoT IT基础设施 服务外包 人力资源/HR外包
储能电池 动力电池 储能 蓄电池
“Benefit farmers, nourish consumers”
“A leading enterprise in the domestic intelligent controller industry”
“A Top 500 Chinese enterprise integrating seven major industries includ”
“为客户创造价值”
“Over 1,000 fast-food restaurants nationwide”
“一家拥有70余年辉煌历史的制药企业”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“一家技术驱动型智能零售服务商”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates